ARTICLE. Resource Utilization and Contaminated Blood Cultures in Children at Risk for Occult Bacteremia
|
|
- Bethany Montgomery
- 6 years ago
- Views:
Transcription
1 Resource Utilization and Contaminated Blood Cultures in Children at Risk for Occult Bacteremia Gershon S. Segal, MD; James M. Chamberlain, MD ARTICLE Objective: To measure the increases in resource utilization and hospital charges associated with the evaluation of contaminated blood cultures obtained from emergency department patients at risk for occult bacteremia. Design: Retrospective medical record review. Setting: Emergency department of an urban, universityaffiliated pediatric referral center. Patients: Children aged 3 to 36 months with blood cultures positive for bacterial growth obtained between January 1994 and October Main Outcome Measures: Increased resource utilization related to contaminated blood culture follow-up, including telephone contact, return emergency department visits, additional diagnostic tests and therapies performed at reevaluation, and hospital admissions. Hospital charges for these additional services were tabulated. Results: Of 8306 children who had blood cultures drawn, 491 (5.9%) had positive findings. Four hundred eightyfive (98.8%) of these were available for review. Two hundred seventy-six (57%) of 485 were excluded from final analysis. Of the remaining 209 patients at risk for occult bacteremia, 85 (41%) had cultures that grew contaminants only. Follow-up of these 85 patients generated 106 telephone calls, 49 return visits to the emergency department, 102 additional diagnostic tests, 18 doses of parenteral antibiotics, and 12 hospital admissions with a combined length of stay of 24 days. This resulted in additional charges of $78 904, or an additional $642 per true pathogen recovered. Conclusions: Contaminated blood cultures obtained from children at risk for occult bacteremia lead to substantial increases in resource utilization and hospital charges. These untoward effects should be accounted for in formal decision analyses regarding the management of occult bacteremia. Arch Pediatr Adolesc Med. 2000;154: From the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Md (Dr Segal); the George Washington University School of Medicine and Health Sciences, and Children s National Medical Center, Washington, DC (Dr Chamberlain). OCCULT bacteremia (OB) occurs in the emergency department (ED) setting in 1.6% to 3.0% of children aged 3 to 36 months with a temperature higher than or equal to 39 C and with no focus of infection. 1,2 Despite multiple studies concerning the optimum approach for these patients, controversy continues regarding the use of diagnostic tests and presumptive antibiotic therapy. 3-6 Practice guidelines from recommend obtaining a blood culture and treating with antibiotics all children with a white blood cell count greater than or equal to /L. Variations on the implementation of these guidelines are common in clinical practice. 8 Blood culture contamination is a widespread problem, to a greater degree in the pediatric population than in adults. 9 Reported contamination rates from a variety of clinical settings range from 1% to 10% It is not surprising then that among blood cultures with positive findings, the ratio of contaminants to true pathogens is nearly 1: Previously published decision analyses of strategies for the management of children at risk for OB paid varying degrees of attention to the effects of contaminated blood cultures on total cost All must agree, however, that as the blood culture contamination rate increases (ie, the specificity of the blood culture decreases), the attractiveness of any strategy that employs blood cultures decreases. The purpose of this study was to measure the increases in resource utilization and hospital charges incurred in evaluating contaminated blood cultures obtained from children in the ED at risk for OB in order to quantify the negative consequences of obtaining blood cultures in this setting. 469
2 MATERIALS AND METHODS This study was performed at Children s National Medical Center in Washington, DC, an urban, university-affiliated pediatric referral center. Although no formal policy exists in the ED regarding febrile children aged 3 to 36 months, it is common practice to obtain a complete blood cell count and blood culture for patients at risk for OB. Blood cultures are obtained by trained nurses and nurse technicians after preparing the skin with alcohol, then povidone-iodine solution, which is supplied as swab sticks with 10% povidone-iodine solution, equivalent to 1% available iodine. Three swabs are used. Contact of the povidoneiodine solution with the skin is allowed for at least 30 seconds prior to venipuncture. Specimens of 0.5 ml to 1 ml of blood are drawn through a butterfly needle or freshly inserted intravenous (IV) catheter and then transferred to a blood culture bottle using a straight needle. In the early part of the study period, both aerobic and anaerobic blood cultures were sent to the laboratory (BacTAlert; Organon Teknika Corp, Durham, NC). Microbiology laboratory protocols were changed in April 1996 so that only a single aerobic blood culture (BacTAlert FAN Aerobic Culture Bottle, Organon Teknika Corp) is sent, unless the patient is deemed at high risk for anaerobic bacteremia (eg, peritonitis with sepsis). For the purpose of this study, a patient with positive culture findings from either one or both bottles was considered as having a single positive culture. The laboratory uses a continuously monitored blood culture system that detects bacterial growth based on changes in the ph of the broth. When blood culture findings are reported positive by the microbiology laboratory, the attending physician in the ED is notified of the time interval until the culture became positive and the Gram stain characteristics. Further evaluation of the patient is then based on the child s clinical status, the persistence of fever, and the attending physician s impression of whether the organism represents a pathogen or a contaminant. The attending physician, at his or her discretion, may call the child back to the ED for reevaluation, further diagnostic tests, and possible inpatient admission. Final identification and sensitivity of the organism are not available for at least 24 hours after the initial report of positive culture findings. Two lists of blood cultures were used for this analysis. One list was of all blood cultures drawn from children aged 3 to 36 months in the ED between January 1994 and October 1996, and the second list was of only cultures with positive findings identified during the same time. We reviewed the medical records of those children with positive culture findings and identified all of the children in this group at risk for OB. Specifically, inclusion criteria included any child aged 3 through 36 months with a temperature higher than or equal to 39 C and a blood culture that yielded at least 1 bacterial organism. Exclusion criteria included the following: (1) presence of an underlying illness that would place the child at higher risk for bacteremia or its complications (eg, immunodeficiency, malignancy, sickle hemoglobinopathy, congenital heart disease, or long-term steroid use); (2) the presence of an indwelling medical device (eg, central venous line or ventricular shunt); (3) diagnosis of an invasive bacterial disease (eg, pneumonia, cellulitis, or meningitis); (4) admission at the initial ED visit; or (5) maximum temperature (by parental history and in the ED) lower than 39 C. The following data were recorded: clinical and laboratory data from the first ED visit; blood culture characteristics; follow-up of positive culture findings; the number of children who returned to the ED for reevaluation; and any additional diagnostic tests and therapies performed at reevaluation, including parenteral antibiotics and hospital admission. Charges for these follow-up ED visits and admissions were obtained from the hospital s billing department and used for further calculations. The following organisms were considered pathogens: Streptococcus pneumoniae, Haemophilus influenzae type b, Neisseria meningitidis, Salmonella species, group A streptococcus, and group B streptococcus. The following organisms were presumed to be contaminants: coagulase-negative staphylococci, micrococci, -hemolytic streptococci, nonhemolytic streptococci, and diphtheroids. 20 Other organisms, such as Staphylococcus aureus and gram-negative enteric organisms, were categorized as contaminants or pathogens based on the patient s clinical picture, whether subsequent findings from blood cultures were negative, and whether the patient improved without antibiotic therapy. 10 Blood cultures growing both a pathogen and a contaminant were classified as pathogens. If a determination could not be made based on the available data, the culture was classified as indeterminate. Data were analyzed using EPISTAT (EPISTAT Services, Round Rock, Tex). Continuous data were analyzed with t test, and nominal data were analyzed using 2 or Fisher exact test. A 2-tailed P.05 was considered significant. The study was approved by the institutional review board. RESULTS During the 34-month study period, 8306 patients aged 3 to 36 months had peripheral aerobic and/or anaerobic blood cultures drawn. Of these, 491 (5.9%) grew at least 1 bacterial organism. We reviewed 485 (98.8%) of 491 medical records. Six records were not available for review. Two hundred thirty-seven of 485 blood cultures with positive findings grew contaminants. Thus, the overall contamination rate during the study period was 237 (2.9%) of The contamination rate did not differ significantly (P =.50) between the periods when the standard aerobic and anaerobic bottles were sent (2.9%) and when the single aerobic bottle was sent (2.5%). Among the blood cultures positive for bacterial growth, findings from aerobic cultures were positive in 424 (87%) of 485 cases. Thus, findings from anaerobic cultures were positive only 13% of the time when findings from the aerobic culture were negative. This proportion was the same for the overall positive rate and the contamination rate. Anaerobic blood culture bottles had significantly lower (P.01) rates of overall positive findings from blood cultures and contaminated cultures (187 [2.8%] and 72 [1.1%] of 6624, respectively) than the aerobic culture bottles (424 [5.1%] and 205 [2.5%] of 8306, respectively). After reviewing the records, 276 (57%) of the cases were excluded (Table 1). Thus, 209 patients (43%) were eligible for analysis (Figure). 470
3 Table 1. Excluded Patients Exclusion Criteria No. Excluded Admitted at first visit 139 Underlying illness 69 Invasive disease 30 Temperature 39 C 27 Indwelling medical device 11 Total Excluded 276 Negative Culture Findings, 7815 (94.1%) All Bacterial Cultures, 8306 Positive Culture Findings, 491 (5.9%) Table 3. Contaminants Organism No. (%) Staphylococcus species, coagulase negative 42 (49.4) Streptococcus viridans group 5 (5.9) Micrococcus species 3 (3.5) Corynebacterium species (diphtheroids) 2 (2.4) Nonhemolytic Streptococcus species, not group D 2 (2.4) Streptococcus species, group D (not Enterococcus) 2 (2.4) Other single organisms* 6 (7.1) Multiple organisms 23 (27.1) Total 85 (100.2) *One each: Acinetobacter calcoaceticus variant Iwoffi, Agrobacterium radiobacter, Corynebacterium species, not jeikeium, Peptostreptococcus micros, Propionibacterium species, Stomatococcus species. Total does not equal 100 because of rounding. Records Not Reviewed, 6 (1%) Derivation of the 209 patients. Table 2. Pathogens Records Excluded, 276 (57%) Records Reviewed, 485 (99%) Records Analyzed, 209 (43%) Organism No. (%) Streptococcus pneumoniae 102 (82.9) Salmonella species 11 (8.9) Staphylococcus aureus 3 (2.4) Group A streptococcus 2 (1.6) Escherichia coli 2 (1.6) Neisseria meningitidis 2 (1.6) Moraxella catarrhalis 1 (0.8) Haemophilus influenzae type b 0 (0) Total 123 (99.8)* *Total does not equal 100 because of rounding. Of 209 blood cultures eligible for analysis, findings from 123 were classified as pathogens; 85, as contaminants; and 1, as indeterminate. Table 2 gives the pathogens identified. One hundred two (83%) of 123 pathogens were S pneumoniae, while Salmonella species (11 isolates, 9%) were the second most common organism. No findings from blood cultures were positive for H influenzae type b during this time. Table 3 gives the organisms identified from 85 contaminated cultures. Of these 85, 62 grew a single organism, while 23 grew multiple organisms (17 grew 2 organisms, and 2 each grew 3, 4, and 5 organisms). Thus, a total of 120 organisms were identified from 85 cultures. Coagulase-negative staphylococci accounted for approximately 50% of the contaminants. The microbiology laboratory performed 94 tests of antimicrobial sensitivities for these 120 contaminant organisms. A comparison between those cultures that grew contaminants and those that grew pathogens is shown in Table 4. There was no statistically significant difference in mean age between the 2 groups (14.9 vs 15.6 months) (P =.48). Mean temperature at presentation (40.0 C vs 40.4 C) (P.001), mean white blood cell count Table 4. Comparison Between Contaminants and Pathogens* Contaminants (n = 85) Pathogens (n = 123) P Age, mo 14.9 (8.2) 15.6 (7.1).48 Temperature, C 40.0 (0.6) 40.4 (0.5).001 WBC, 10 9 /L 13.7 (6.2) 20.5 (7.7).001 WBC /L, 31/74 (42) 85/112 (76).001 No. (%) ANC, 10 9 /L 6.9 (4.5) 13.8 (6.5).001 ANC /L, 18/74 (24) 82/112 (73).001 No. (%) BNR 0.18 (0.30) 0.18 (0.27).96 BNR 0.2, No. (%) 18/73 (25) 34/111 (31).47 Time to positivity, h 33.1 (22.6) 19.9 (8.3).001 Time to positivity 24 h, No. (%) 34/84 (40) 107/122 (88).001 *WBC indicates white blood cell count; ANC, absolute neutrophil count; BNR, band:neutrophil ratio; and time to positivity, see the Results section. Values are given as mean (SD) except where indicated. Only 74 of 85 patients with contaminants had a WBC with a differential cell count performed initially. Only 112 of 123 patients with pathogens had a WBC with a differential cell count performed initially. One patient in each group had an automated WBC performed, and a BNR could not be computed. Time to positivity was not available for 1 patient in each group. (13.7 vs /L) (P.001), and mean absolute neutrophil count (6.9 vs /L) (P.001) from the initial visit were all significantly lower in the contaminants group. The mean number of hours elapsed between the time the blood culture was obtained and the time it was reported as positive to the ED attending physician or fellow (time to positivity) was significantly longer in the contaminants group (33.1 vs 19.9 hours) (P.001). Emergency department physicians documented 106 telephone calls to families and/or primary care physicians regarding positive findings from cultures. Of 85 children with contaminated cultures, 49 were asked to return to the ED for further evaluation and did so; 25 were not asked to return to the ED; and 11 could not be reached by either telephone or mail. Data regarding the telephone conversation were available for 45 of 49 children who were asked to return and for 20 of 25 who were not asked to return. The 2 groups did not differ by age (mean 471
4 age, 14 vs 15 months) (P =.65) or having a Gram stain suggestive of a pathogen (18 [40%] of 45 vs 4 [20%] of 20) (P =.20). There were significant differences between those asked to return and those not asked to return for the following variables: the mean time to positivity (mean [SD] time, 28.7 [17.0] hours vs 39.2 [18.5] hours) (P =.03); the percentage given ceftriaxone sodium prior to hospital discharge from the first visit (21 [43%] of 49 vs 5 [14%] of 36) (P =.004); the percentage of those described as febrile by the parent (21 [47%] of 45 vs 0 [0%] of 20) (P.001); and the percentage of those described by the parents as being sleepy, fussy, or irritable (10 [22%] of 45 vs 0 [0%] of 20) (P =.02). At the follow-up ED visits for these 49 patients, 102 additional diagnostic tests were performed, including 44 repeated blood cultures, 27 complete blood cell counts, 7 urinalyses, 6 urine cultures, 2 lumbar punctures, 2 respiratory syncytial virus antigen detection tests, 6 chest radiographs, 4 basic metabolic panels, 2 sickle hemoglobin solubility tests, 1 stool culture, and 1 erythrocyte sedimentation rate. Thirty-six of 49 returning patients were discharged home from the ED, 18 of whom were given a dose of parenteral ceftriaxone prior to discharge. Twelve of 49 were admitted to the hospital because of presumed bacteremia for an aggregate total of 24 hospital days. One additional patient was admitted at the second visit because of hypernatremic dehydration; this hospital stay was not included in further calculations. Those who were admitted tended to be older (19.2 vs 12.2 months) (P =.01) and have higher temperatures at the return ED visit (38.6 C vs 37.7 C) (P =.02). All 12 patients who were admitted were either persistently febrile (at home or in the ED); described by the parents as being sleepy, fussy, or irritable ; or had a Gram stain suggestive of the growth of a pathogen (eg, gramnegative rods). The sample was not large enough to compare the practice patterns of different physicians. Additional charges billed to these 85 patients for these services totaled $ The breakdown of these charges is as follows: $6204 (8% of total) for 94 tests of antimicrobial sensitivity ($66 per test); $ (31% of total) for 36 patients seen for follow-up and discharged from the ED (mean, $675); and $ (61% of total) for 12 patients admitted at the second ED visit (mean, $4033). These figures include hospital and physician charges. These charges of $ represent an additional $642 for identifying each of 123 pathogens recovered in our study. If we assume that the risk of meningitis for untreated pneumococcal bacteremia is 3% to 6% 21,22 and that presumptive treatment with parenteral (and possibly oral) antibiotics reduces that risk to 0.4%, 21 then by identifying and treating these 123 patients with OB (83% of whom had cultures that grew pneumococci and 82% of whom were treated with parenteral and/or oral antibiotics), we prevented the development of 2.6 to 5.6 cases of meningitis. This translates to additional charges of $ to $ per case of meningitis prevented. These data represent hospital charges to the patients and not costs. The approximate charge-to-cost ratio in our institution is 3.3:1.0; therefore, the approximate additional cost per pathogen identified is $195, and the additional cost per each case of meningitis prevented is $4270 to $9196. COMMENT Previous studies involving adult inpatients 15 or a combination of pediatric inpatients and outpatients 23 concluded that contaminated blood cultures contribute to increased resource utilization (length of hospital stay, laboratory tests, and antimicrobial therapy). Our study, conducted in the specific clinical context of children at risk for OB, confirms the results of these previous studies. Our results demonstrate that the hospital charges incurred in the evaluation of contaminated blood are substantial. Additional charges stemming from the evaluation of 85 patients with contaminated blood cultures totaled $78 904, of which 61% was accounted for by patients admitted to the hospital at the second ED visit. These charges must be taken into account when calculating the cost of identifying the 123 patients with pathogenic bacteremia. Lieu et al, 18 in the cost-effectiveness portion of their study, estimated that for each 1% increase in the contamination rate (or decrease in the specificity of the blood culture), an additional $1303 in 1989 dollars would be spent in preventing each case of meningitis. Based on changes in the consumer price index for medical care services between 1989 (the year of the study by Lieu et al 18 ) and 1995 (the middle year of this 3-year study), $1303 in 1989 medical care service dollars would be equivalent to $1962 in 1995 medical care service dollars. 24 The overall contamination rate in our ED during the study period was approximately 3%; based on their assumptions, we would have expected additional costs of $5886 (in 1995 dollars) per case of meningitis prevented. This correlates well with the $4000 to $9000 estimated here. There are several limitations to our study. We could not easily obtain a denominator of the number of children who were seen during that time who were at risk for OB, both those who did and did not have blood cultures obtained. Thus, our estimates of the risk of bacterial meningitis were derived from previous literature rather than the actual risk in our patient population. Also, we did not record whether the blood specimen was drawn through a butterfly needle or an IV catheter because that information was not readily available. Although there is some concern that drawing blood for a culture through a freshly inserted IV catheter may increase the rate of contamination, data from Isaacman and Karasic 11 suggest otherwise. Also, we could not discern to what degree individual physician practice patterns played a role in the decision to perform further laboratory tests or admit a particular patient to the hospital. This may make it difficult to generalize our results to an institution at which a fixed protocol exists for handling blood cultures that are positive for bacterial growth. An additional weakness to the study is that our monetary figures are based not on costs but on charges billed to the patients. We attempted to correct for this by dividing the total charges by the charge-to-cost ratio in our institution. This was not a formal cost analysis, however, and there are several other variables for which the costs could have been included but were not: (1) time 472
5 spent by ED attending physicians contacting family members and primary care physicians; (2) follow-up visits with primary care physicians; and (3) societal costs related to time lost from work by parents. Lastly, no attempt was made to place a dollar amount on the parental anxiety generated by the suggestion that one s child had bacteria in his or her blood. Based on the findings of previous authors, we suggest the following methods to reduce costs generated by contaminated blood cultures obtained from children at risk for OB: (1) Attempt to reduce the number of contaminants through stricter adherence to sterile venipuncture technique. Isaacman and Karasic 10 identified failing to wait for the povidone-iodine solution to dry on the skin (usually requiring 60 seconds) as the main culprit in higher contamination rates. (2) Increase the ratio of pathogens to contaminants by improving the sensitivity of the blood culture for recovering pathogens. This may be achieved by increasing the volume of blood inoculated into the blood culture bottle. 12 (3) A clinician faced with the report of a contaminated blood culture should use knowledge of Gram stain morphology and the time to positivity to help determine whether the bacterial growth represents a pathogen or contaminant. Kornberg et al 20 demonstrated that a culture that grows organisms after 24 hours and has a Gram stain showing gram-positive cocci in clusters or gram-positive rods is overwhelmingly likely to be a contaminant. (4) Molecular diagnostic techniques, such as polymerase chain reaction, may be able to more specifically distinguish between pathogens and contaminants This may be accomplished at the time the culture is drawn or when the culture becomes positive for bacterial growth. Clearly, in an age during which H influenzae type b disease has declined dramatically and during which concerns mount over increasing antimicrobial resistance, the approach to care for the child at risk for OB should be reevaluated, and the costs of contaminated blood cultures must be taken into account. Accepted for publication October 18, Presented in part at the Annual Meeting of the Ambulatory Pediatric Association, New Orleans, La, May 5, We gratefully acknowledge the assistance of Joseph Campos, PhD, Director of Microbiology and Laboratory Informatics, Children s National Medical Center, Washington, DC. Corresponding author: Gershon S. Segal, MD, Division of Pediatric Emergency Medicine, Johns Hopkins University School of Medicine, 600 N Wolfe St, CMSC 144, Baltimore, MD ( gsegal@jhmi.edu). REFERENCES 1. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post- Haemophilus influenzae type b era. Arch Pediatr Adolesc Med. 1998;152: Fleisher GR, Rosenberg N, Vinci R, et al. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young febrile children at risk for occult bacteremia. J Pediatr. 1994;124: Kramer MS, Shapiro ED. Management of the young febrile child: a commentary on recent practice guidelines. Pediatrics. 1997;100: Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH, Powell KR. Commentary on practice guidelines. Pediatrics. 1997;100: Schriger DL. Clinical guidelines in the setting of incomplete evidence. Pediatrics. 1997;100: Bauchner H, Pelton SI. Management of the young febrile child: a continuing controversy. Pediatrics. 1997;100: Baraff LJ, Bass JW, Fleisher GR, et al. Practice guidelines for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics. 1993;92: Ros SP, Herman BE, Beissel TJ. Occult bacteremia: is there a standard of care? Pediatr Emerg Care. 1994;10: Campos JM. Detection of bloodstream infections in children. Eur J Clin Microbiol Infect Dis. 1989;8: Isaacman DJ, Karasic RB. Lack of effect of changing needles on contamination of blood cultures. Pediatr Infect Dis J. 1990;9: Isaacman DJ, Karasic RB. Utility of collecting blood cultures through newly inserted intravenous catheters. Pediatr Infect Dis J. 1990;9: Isaacman DJ, Karasic RB, Reynolds EA, Kost SI. Effect of number of blood cultures and volume of blood on detection of bacteremia in children. J Pediatr. 1996; 128: MacGregor RR, Beaty HN. Evaluation of positive blood cultures: guidelines for early differentiation of contaminated from valid positive cultures. Arch Intern Med. 1972;130: McGowan JE, Bratton L, Klein JO, Finland M. Bacteremia in febrile children seen in a walk-in pediatric clinic. N Engl J Med. 1973;288: Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA. 1991;265: Kramer MS, Lane DA, Mills EL. Should blood cultures be obtained in the evaluation of young febrile children without evident focus of bacterial infection? a decision analysis of diagnostic management strategies. Pediatrics. 1989;84: Downs SM, McNutt RA, Margolis PA. Management of infants at risk for occult bacteremia: a decision analysis. J Pediatr. 1991;118: Lieu TA, Schwartz JS, Jaffe DM, Fleisher GR. Strategies for diagnosis and treatment of children at risk for occult bacteremia: clinical effectiveness and costeffectiveness. J Pediatr. 1991;118: Yamamoto LG, Worthley RG, Melish ME, Seto DSY. A revised decision analysis of strategies in the management of febrile children at risk for occult bacteremia. Am J Emerg Med. 1998;16: Kornberg AE, Jain N, Dannenhoffer R. Evaluation of false-positive blood cultures: guidelines for early detection of contaminated cultures in febrile children. Pediatr Emerg Care. 1994;10: Baraff LJ, Oslund S, Prather M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics. 1993;92: Rothrock SG, Harper MB, Green SM, et al. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? a meta-analysis. Pediatrics. 1997;99: Thuler LC, Jenicek M, Turgeon JP, Rivard M, Lebel P, Lebel MH. Impact of a false-positive blood culture result on the management of febrile children. Pediatr Infect Dis J. 1997;16: US Dept of Labor, Bureau of Labor Statistics Web site. Consumer price index for all urban consumers, US city average, medical care services, = 100. Available at: Accessed September 23, Zhang Y, Isaacman DJ, Wadowsky RM, Rydquist-White J, Post JC, Ehrlich GD. Detection of Streptococcus pneumoniae in whole blood by PCR. J Clin Microbiol. 1995;33: Friedland LR, Menon AG, Reising SF, Ruddy RM, Hassett DJ. Development of a polymerase chain reaction assay to detect the presence of Streptococcus pneumoniae DNA. Diagn Microbiol Infect Dis. 1994;20: Rudolph KM, Parkinson AJ, Black CM, Mayer LW. Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia. J Clin Microbiol. 1993;31:
ARTICLE. Subhankar Bandyopadhyay, MD; Jo Bergholte, MS; Charles D. Blackwell, MD; Jason R. Friedlander, MD; Halim Hennes, MD, MS
ARTICLE Risk of Serious Bacterial Infection in Children With Fever Without a Source in the Post Haemophilus influenzae Era When Antibiotics Are Reserved for Culture-Proven Bacteremia Subhankar Bandyopadhyay,
More informationThe Clinical Significance of Blood Cultures. Presented BY; Cindy Winfrey, MSN, RN, CIC, DON- LTC TM, VA- BC TM
The Clinical Significance of Blood Cultures Presented BY; Cindy Winfrey, MSN, RN, CIC, DON- LTC TM, VA- BC TM OVERVIEW Blood cultures are considered an important laboratory tool used to diagnose serious
More informationShould blood cultures be obtained in all infants 3 to 36 months presenting with significant fever? abstract CLINICAL QUESTION REVIEW
CLINICAL QUESTION REVIEW CQR is a recurring section in Hospital Pediatrics where authors start with a relevant clinical question, find and synthesize the recent literature and provide their best answer
More informationThe evaluation of well-appearing febrile children
CLINICAL PRACTICE Prevalence of Occult Bacteremia in Children Aged 3 to 36 Months Presenting to the Emergency Department with Fever in the Postpneumococcal Conjugate Vaccine Era Matthew Wilkinson, MD,
More informationFever Interval before Diagnosis, Prior Antibiotic Treatment, and Clinical Outcome for Young Children with Bacterial Meningitis
MAJOR ARTICLE Fever Interval before Diagnosis, Prior Antibiotic Treatment, and Clinical Outcome for Young Children with Bacterial Meningitis Bema K. Bonsu 1 and Marvin B. Harper 2 1 Department of Medicine,
More informationBlood cultures in ED. Dr Sebastian Chang MBBS FACEM
Blood cultures in ED Dr Sebastian Chang MBBS FACEM Why do we care about blood cultures? blood cultures are the most direct method for detecting bacteraemia in patients a positive blood culture: 1. can
More informationUpdated Review of Blood Culture Contamination
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2006, p. 788 802 Vol. 19, No. 4 0893-8512/06/$08.00 0 doi:10.1128/cmr.00062-05 Copyright 2006, American Society for Microbiology. All Rights Reserved. Updated Review
More informationPDFlib PLOP: PDF Linearization, Optimization, Protection. Page inserted by evaluation version
PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version www.pdflib.com sales@pdflib.com ACAD EMERG MED d December 2004, Vol. 11, No. 12 d www.aemj.org 1297 A Low Peripheral
More informationReducing Blood Culture Contamination in Hospitalized Pediatric Patients
ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 200-208 http://www.ijcmas.com Original Research Article Reducing Blood Culture Contamination in Hospitalized Pediatric Patients S. H. Khater Enas 1 * and Taha
More information1. Introduction Algorithm: Infant with Fever 0-28 Days Algorithm: Infant with Fever Days...3
These guidelines are designed to assist clinicians and are not intended to supplant good clinical judgement or to establish a protocol for all patients with this condition. MANAGEMENT OF FEVER 38 C (100.4F)
More informationBlood culture 壢新醫院 病理檢驗科 陳啟清技術主任
Blood culture 壢新醫院 病理檢驗科 陳啟清技術主任 A Positive Blood Culture Clinically Important Organism Failure of host defenses to contain an infection at its primary focus Failure of the physician to effectively eradicate,
More informationFever Without a Source Age: 0-28 Day Pathway - Emergency Department Evidence Based Outcome Center
Age: 0-28 Day Pathway - Emergency Department EXCLUSION CRITERIA Toxic appearing No fever Born < 37 weeks gestational age INCLUSION CRITERIA Non-toxic with temperature > 38 C (100.4 F) < 36 C (96.5 F) measured
More informationFaculty Disclosure. Stephen I. Pelton, MD. Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest.
Faculty Disclosure Stephen I. Pelton, MD Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest. Advances in the management of fever in infants 0 to 3 and
More informationLab 4. Blood Culture (Media) MIC AMAL-NORA-ALJAWHARA 1
Lab 4. Blood Culture (Media) 2018 320 MIC AMAL-NORA-ALJAWHARA 1 Blood Culture 2018 320 MIC AMAL-NORA-ALJAWHARA 2 What is a blood culture? A blood culture is a laboratory test in which blood is injected
More information320 MBIO Microbial Diagnosis. Aljawharah F. Alabbad Noorah A. Alkubaisi 2017
320 MBIO Microbial Diagnosis Aljawharah F. Alabbad Noorah A. Alkubaisi 2017 Blood Culture What is a blood culture? A blood culture is a laboratory test in which blood is injected into bottles with culture
More informationFever without Localizing Signs
PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management SECTION B Cardinal Symptom Complexes 14 Fever without Localizing Signs Eugene D. Shapiro
More informationFever in the Newborn Period
Fever in the Newborn Period 1. Definitions 1 2. Overview 1 3. History and Physical Examination 2 4. Fever in Infants Less than 3 Months Old 2 a. Table 1: Rochester criteria for low risk infants 3 5. Fever
More informationFever in neonates (age 0 to 28 days)
Fever in neonates (age 0 to 28 days) INCLUSION CRITERIA Infant 28 days of life Temperature 38 C (100.4 F) by any route/parental report EXCLUSION CRITERIA Infants with RSV Febrile Infant 28 days old Ill
More informationPEDIATRICS/ORIGINAL RESEARCH
PEDIATRICS/ORIGINAL RESEARCH Pneumococcal Bacteremia in Febrile Infants Presenting to the Emergency Department Before and After the Introduction of the Heptavalent Pneumococcal Vaccine Keri L. Carstairs,
More informationBacteremia Risk and Outpatient Management of Febrile Patients With Sickle Cell Disease
ARTICLE Bacteremia Risk and Outpatient Management of Febrile Patients With Sickle Cell Disease AUTHORS: Marc N. Baskin, MD, a,b Xin Lyn Goh, BMedSc, c Matthew M. Heeney, MD, b,d and Marvin B. Harper, MD
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationBeyond the Reflex Arc: An Evidence-Based Discussion of the Management of Febrile Infants
Beyond the Reflex Arc: An Evidence-Based Discussion of the Management of Febrile Infants Cole Condra, MD MSc Division of Emergency Medical Services Children s Mercy Hospital October 1, 2011 Disclosure
More informationBlood Culture Collection and Interpretation
Blood Culture Collection and Interpretation Catherine Ernst, RN,PBT(ASCP) Blood Cultures Indications for blood culture collection Proper method for blood culture collection Interpreting a blood culture
More informationGetting the Point of Injection Safety
Getting the Point of Injection Safety Barbara Montana, MD, MPH, FACP Medical Director Communicable Disease Service Outbreak of Enterococcus faecalis endocarditis associated with an oral surgery practice
More informationFever in Babies. Too much testing or not enough testing? Martin E. Weisse, M.D. Pediatric Infectious Diseases
Fever in Babies Too much testing or not enough testing? Martin E. Weisse, M.D. Pediatric Infectious Diseases Disclosures I have nothing to disclose Learning Objectives At the end of the talk, participants
More informationJ of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 4/ Issue 66/ Aug 17, 2015 Page 11432
BLOOD CULTURE AND BACTEREMIA PREDICTORS IN INFANTS LESS THAN ONE YEAR OF AGE WITH FEVER WITHOUT SOURCE (FWS) Y. G. Sathish Kumar 1, A. Udayamaliny 2, S. Ankitha 3 HOW TO CITE THIS ARTICLE: Y. G. Sathish
More informationPEACEHEALTH LABORATORIES
360-414-2306 www.peacehealthlabs.org Critical Values Call List - Longview Critical values are reported per the criteria published below. Laboratory results meeting these criteria indicate potential life-threatening
More informationmore than 90% of the bacterial isolates identified as Streptococcus pneumoniae
Research Highlights Highlights from the latest papers in pediatric emergency medicine NEWS & VIEWS Wendy L Woolley & John H Burton Author for correspondence Department of Emergency Medicine Albany Medical
More informationEnrichment culture of CSF is of limited value in the diagnosis of neonatal meningitis
Enrichment culture of CSF is of limited value in the diagnosis of neonatal S. H. Chaudhry, D. Wagstaff, Anupam Gupta, I. C. Bowler, D. P. Webster To cite this version: S. H. Chaudhry, D. Wagstaff, Anupam
More informationMedline Abstracts for References 15,30-37
Page 1 of 5 Official reprint from UpToDate www.uptodate.com 2013 UpToDate Medline Abstracts for References 15,30-37 of 'Fever without a source in children 3 to 36 months of age' 15 Check for full text
More informationFever is one of the most common presenting
Fever in Pediatric Primary Care: Occurrence, Management, and Outcomes Jonathan A. Finkelstein, MD, MPH* ; Cindy L. Christiansen, PhD*; and Richard Platt, MD, MS* Abstract. Objective. To describe the epidemiology,
More informationBLOOD CULTURE SPECIMEN COLLECTION. Skills: 40 points. Objectives:
EXERCISE 7: BLOOD CULTURE SPECIMEN COLLECTION Skills: 40 points Objectives: 1. Differentiate between sterile and antiseptic techniques. 2. Define the following terms: FUO, septicemia, bacteremia, aerobic
More informationTime to Detection of Bacterial Cultures in Infants Aged 0 to 90 Days
RESEARCH ARTICLE Time to Detection of Bacterial Cultures in Infants Aged 0 to 90 Days AUTHORS Rianna C. Evans, MD, Bryan R. Fine, MD, MPH Division of Pediatric Hospital Medicine, Department of Pediatrics,
More information35.0. ug/ml Trough. 8.0 Carbamazepine 15.0 ug/ml Digoxin 2.5 ng/ml Gentamicin Peak Random Trough
The following are a list by department of Critical (Panic) Values: CHEMISTRY TEST LESS THAN GREATER THAN UNITS Glucose 0-7days 40 200 mg/dl Glucose > 7 days 50 400 mg/dl Glucose, CSF 25 mg/dl Sodium 121
More informationFevers and Seizures in Infants and Young Children
Fevers and Seizures in Infants and Young Children Kellie Holtmeier, PharmD Pediatric Clinical Pharmacist University of New Mexico Hospital Disclosure I have no conflicts of interest 1 Pharmacist Objectives
More informationWork-up of Respiratory Specimens Now you can breathe easier
34 th Annual Meeting Southwestern Association of Clinical Microbiology Work-up of Respiratory Specimens Now you can breathe easier Yvette S. McCarter, PhD, D(ABMM) Director, Clinical Microbiology Laboratory
More informationDirect Identification of Gram-Positive Cocci from Routine Blood Cultures by Using AccuProbe Tests
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2004, p. 5609 5613 Vol. 42, No. 12 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.12.5609 5613.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationNormal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine
Normal Human Flora (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine 2014-2015 Objectives Describe important human normal flora. Demonstrate the epidemiology of human normal flora. Determine
More informationA Multicentre Study about Pattern and Organisms Isolated in Follow-up Blood Cultures
Ann Clin Microbiol Vol., No., March, 0 http://dx.doi.org/0./acm.0... ISSN -0 A Multicentre Study about Pattern and Organisms Isolated in Follow-up Blood Cultures Jeong Hwan Shin, Eui Chong Kim, Sunjoo
More informationMicrobiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians
MEMORANDUM DATE: October 1, 2009 TO: FROM: SUBJECT: Microbiology Laboratory Directors, Infection Preventionists, Primary Care Providers, Emergency Department Directors, Infectious Disease Physicians Michael
More informationRespiratory Pathogen Panel TEM-PCR Test Code:
Respiratory Pathogen Panel TEM-PCR Test Code: 220000 Tests in this Panel Enterovirus group Human bocavirus Human coronavirus (4 types) Human metapneumovirus Influenza A - Human influenza Influenza A -
More informationREACTIVE THROMBOCYTOSIS IN FEBRILE CHILDREN WITH SERIOUS BACTERIAL INFECTION Amita Jane D Souza 1, Anil Shetty 2, Divya Krishnan K 3
REACTIVE THROMBOCYTOSIS IN FEBRILE CHILDREN WITH SERIOUS BACTERIAL INFECTION Amita Jane D Souza 1, Anil Shetty 2, Divya Krishnan K 3 HOW TO CITE THIS ARTICLE: Amita Jane D Souza, Anil Shetty, Divya Krishnan
More informationAciphin Ceftriaxone Sodium
Aciphin Ceftriaxone Sodium Only for the use of Medical Professionals Description Aciphin is a bactericidal, long-acting, broad spectrum, parenteral cephalosporin preparation, active against a wide range
More informationNEONATAL SEPSIS. Dalima Ari Wahono Astrawinata Departemen Patologi Klinik, FKUI-RSCM
NEONATAL SEPSIS Dalima Ari Wahono Astrawinata Departemen Patologi Klinik, FKUI- Background Neonatal sepsis : Early-onset Late-onset Early-onset : mostly premature neonates Within 24 hours 85% 24-48 hours
More informationMonitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015
Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015 1. The cumulative cases report since December 2010 and cases report during January to March 2015 During
More informationUnit II Problem 2 Microbiology Lab: Pneumonia
Unit II Problem 2 Microbiology Lab: Pneumonia - What are the steps needed to obtain a proper sputum specimen? You need the following: A wide-mouth labeled container. Gloves. Water. Mouth wash + tissues.
More information2018 CNISP HAI Surveillance Case definitions
2018 CNISP HAI Surveillance Case definitions The following case definitions for the surveillance of healthcare-associated infections (HAIs) are used by all acute-care hospitals that participate in the
More informationAlberta Health Services Infection Prevention and Control - Initiatives and Services. Surveillance Protocol January 12, 2010 Rev.
Alberta Health Services Infection Prevention and Control - Initiatives and Services Hospital Acquired Bloodstream Infections (HABSI) Hospital Wide- in Acute Care and Acute Rehabilitation Facilities Surveillance
More informationDisclosures. Background. Definitions. Why Worry about these Infants? Goals. Bacterial infection in the neonate and young infant: a review
Disclosures Bacterial infection in the neonate and young infant: a review Russell J. McCulloh, MD Med-Peds Infectious Diseases August 8, 2017 I have no financial interests to disclose Funding: Eva and
More informationBacterial Identification
JOURNAL OF CLINICAL MICROBIOLOGY, July 1994, p. 1757-1762 0095-1137/94/$04.00+0 Copyright C 1994, American Society for Microbiology Vol. 32, No. 7 Clinical Impact of Rapid In Vitro Susceptibility Testing
More informationBlood Culture Contamination Rates after Skin Antisepsis with Chlorhexidine Gluconate versus Povidone-Iodine in a Pediatric Emergency Department
infection control and hospital epidemiology february 2010, vol. 31, no. 2 original article Blood Culture Contamination Rates after Skin Antisepsis with Chlorhexidine Gluconate versus Povidone-Iodine in
More informationBacteriemia and sepsis
Bacteriemia and sepsis Case 1 An 80-year-old man is brought to the emergency room by his son, who noted that his father had become lethargic and has decreased urination over the past 4 days. The patient
More informationRoutine endotracheal cultures for the prediction of sepsis in ventilated babies
Archives of Disease in Childhood, 1989, 64, 34-38 Routine endotracheal cultures for the prediction of sepsis in ventilated babies T A SLAGLE, E M BIFANO, J W WOLF, AND S J GROSS Department of Pediatrics,
More informationCritical Review Form Clinical Prediction or Decision Rule
Critical Review Form Clinical Prediction or Decision Rule Development and Validation of a Multivariable Predictive Model to Distinguish Bacterial from Aseptic Meningitis in Children, Pediatrics 2002; 110:
More informationGuidelines/Guidance/CAP/ Hospitalized Child. PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014
Guidelines/Guidance/CAP/ Hospitalized Child PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014 CAP in Children: Epi Greatest cause of death in children worldwide Estimated > 2 M deaths in children In developed
More informationIMPACT #: Local Inventory #: form 04. Age at admission: d. mo yr. Postal code:
- Date of birth: birth: Date of admission: year month day year month day Age at admission: d mo yr Postal code: Ethnic code: Hospital: Gender: 1 = male 2 = female 1 = Impact 2 = Other local, specify: Code
More informationMicrobiological diagnosis of infective endocarditis; what is new?
Microbiological diagnosis of infective endocarditis; what is new? Dr Amani El Kholy, MD Professor of Clinical Pathology (Microbiology), Faculty of Medicine, Cairo University ESC 2017 1 Objectives Lab Diagnostic
More informationCefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010
Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European
More informationFever Paul L. McCarthy. DOI: /pir
Paul L. McCarthy Pediatr. Rev. 1998;19;401 DOI: 10.1542/pir.19-12-401 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://pedsinreview.aappublications.org/cgi/content/full/19/12/401
More informationMinimizing the Workup of Blood Culture Contaminants: Implementation and Evaluation of a Laboratory-Based Algorithm
JOURNAL OF CLINICAL MICROBIOLOGY, July 2002, p. 2437 2444 Vol. 40, No. 7 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.7.2437 2444.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationon April 30, 2018 by guest
JCM Accepted Manuscript Posted Online 21 October 2015 J. Clin. Microbiol. doi:10.1128/jcm.02024-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. Cost effectiveness of 30-ml blood
More informationINTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES
Upper Respiratory Tract Infections Return to Syllabus INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES General Goal: To know the major mechanisms of defense in the URT, the major mechanisms invaders use
More informationFever is one of the most important reasons for childhood
Fever in the Toddler-Aged Child: Old Concerns Replaced With New Ones Prashant Mahajan, MD, MPH, MBA, Rachel Stanley, MD, MHSA The widespread use of highly effective and safe vaccines against Haemophilus
More informationHuman infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance
Human infection with pandemic (H1N1) 2009 virus: updated interim WHO guidance on global surveillance 10 July 2009 Background This document updates the interim WHO guidance on global surveillance of pandemic
More informationDiagnosis of Pneumococcal Disease
Diagnosis of Pneumococcal Disease Limitations of Surveillance for Invasive Disease David Murdoch University of Otago, Christchurch New Zealand Key Points We are still reliant on culture-based methods for
More informationQ 1 (May-July 2016) Q 2 (August-October 2016) Q 3 (November 2016-January 2017)
Adult ICU: May 2016-July 2017 Table 1a. Counts and rates of positive blood cultures and blood stream infections which meet the case definition in your critical care unit and for all adult critical care
More informationInvestigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt. January 2017
January 2017 Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt Introduction Since the progressive introduction of meningococcal serogroup A conjugate vaccine (MACV) in the
More informationCatheter-Associated Urinary Tract Infection (CAUTI) Event
Catheter-Associated Urinary Tract Infection () Event Introduction: The urinary tract is the most common site of healthcare-associated infection, accounting for more than 30% of infections reported by acute
More informationFEVER. What is fever?
FEVER What is fever? Fever is defined as a rectal temperature 38 C (100.4 F), and a value >40 C (104 F) is called hyperpyrexia. Body temperature fluctuates in a defined normal range (36.6-37.9 C [97.9-100.2
More informationFrequency of Low-Level Bacteremia in Children from Birth to Fifteen Years of Age
JOURNAL OF CLINICAL MICROBIOLOGY, June 2000, p. 2181 2185 Vol. 38, No. 6 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Frequency of Low-Level Bacteremia
More informationDialysis Event Protocol
Dialysis Event Protocol Introduction In 2009, more than 370,000 patients were treated with maintenance hemodialysis in the United States. 1 Hemodialysis patients require a vascular access, which can be
More informationBACTERIOLOGY PROFICIENCY TESTING PROGRAM
BACTERIOLOGY PROFICIENCY TESTING PROGRAM Comprehensive Category September 6, 2016 If you have any questions or comments, please contact either: Dr. Wendy Archinal Nellie Dumas Dr. Kimberlee Musser Phone:
More information4/14/2010. Theoretical purpose of fever? Andrea Marmor, MD, MSEd Assistant Clinical Professor, Pediatrics UCSF April 13, 2010
Andrea Marmor, MD, MSEd Assistant Clinical Professor, Pediatrics UCSF April 13, 2010 Parental touch? Absence of fever more reliable than presence. Axillary and tympanic Vulnerable to environmental and
More informationReactive Thrombocytosis in Febrile Young Infants with Serious Bacterial Infection
R E S E A R C H P A P E R Reactive Thrombocytosis in Febrile Young Infants with Serious Bacterial Infection S FOUZAS, L MANTAGOU, E SKYLOGIANNI AND A VARVARIGOU From the Department of Pediatrics, University
More informationBloodstream infection has been a primary
Bacteremia in children at the University Hospital in Riyadh, Saudi Arabia Fahad Abdullah Al-Zamil Riyadh, Saudi Arabia 118 Background: Bacteremia is a major pediatric health care problem despite the availability
More informationThe Febrile Infant. SJRH ED Rounds Dec By: Robin Clouston
1 The Febrile Infant SJRH ED Rounds Dec 11 2018 By: Robin Clouston 2 Objectives Discuss the risk of serious bacterial infection (SBI) in the neonate or young infant (
More informationSetting The setting was community. The economic study was carried out in the USA.
Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children Lieu T A, Ray G T, Black S R, Butler J C, Klein J O, Breiman R F, Miller M A, Shinefield H R Record
More informationPseudomonas aeruginosa
JOURNAL OF CLINICAL MICROBIOLOGY, July 1983, p. 16-164 95-1137/83/716-5$2./ Copyright C) 1983, American Society for Microbiology Vol. 18, No. 1 A Three-Year Study of Nosocomial Infections Associated with
More informationGood Morning! Welcome Applicants! FRIDAY, N OVEMBER, 7 TH 2014
Good Morning! Welcome Applicants! FRIDAY, N OVEMBER, 7 TH 2014 Prep Question You are camping with a group of boys at a rural campground in the southeastern Unites States when one of the campers is bitten
More informationEvidence-based Management of Fever in Infants and Young Children
Evidence-based Management of Fever in Infants and Young Children Shabnam Jain, MD, MPH Associate Professor of Pediatrics Emory University Medical Director for Clinical Effectiveness Objectives Understand
More informationMaking the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP?
Making the Right Call With Community-Acquired Pneumonia In this article: By Thomas J. Marrie, MD The case of Allyson Allyson, 32, presented to the emergency department with a 48-hour history of anorexia,
More informationFever in Infants: Pediatric Dilemmas in Antibiotherapy
Fever in Infants: Pediatric Dilemmas in Antibiotherapy Jahzel M. Gonzalez Pagan, MD, FAAP Pediatric Emergency Medicine Associate Professor, UPH Medical Advisor, SJCH June 9 th, 2017 S Objectives S Review
More informationThe cost-saving, effective diagnoses of melioidosis in Cambodia. Vanaporn Wuthiekanun Faculty of Tropical Medicine Mahidol University
Angkor hospital for Children at Siem Reap The cost-saving, effective diagnoses of melioidosis in Cambodia Vanaporn Wuthiekanun Faculty of Tropical Medicine Mahidol University Angkor Wat Ta Prohm Bayon
More informationCommunity Acquired Pneumonia. Abdullah Alharbi, MD, FCCP
Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent
More informationCreating a User Defined Pneumonia-Specific Syndrome in ESSENCE. Preventive Medicine Directorate September 2016
Creating a User Defined Pneumonia-Specific Syndrome in ESSENCE Preventive Medicine Directorate September 2016 0 Pneumonia-Specific Syndrome NMCPHC retrospective analyses suggest that surveillance using
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationNeutropenic Fever. CID 2011; 52 (4):e56-e93
Neutropenic Fever www.idsociety.org CID 2011; 52 (4):e56-e93 Definitions Fever: Single oral temperature of 101 F (38.3 C) Temperature 100.4 F (38.0 C) over 1 hour Neutropenia: ANC < 500 cells/mm 3 Expected
More informationHaemophilus influenzae
Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae
More informationAdvanced Pediatric Emergency Medicine Assembly
(+)Joan Shook, MD, FACEP Professor of Pediatrics, Baylor College of Medicine; Chief Safety Officer and Chief Clinical Information Officer, Texas Children's Hospital Advanced Pediatric Emergency Medicine
More informationCHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement
CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement Evidence-Based Assessment of Diagnostic Tests for Ventilator- Associated Pneumonia* Executive Summary Ronald F. Grossman, MD, FCCP; and Alan Fein, MD,
More informationInfective endocarditis
Infective endocarditis Today's lecture is about infective endocarditis, the Dr started the lecture by asking what are the most common causative agents of infective endocarditis? 1-Group A streptococci
More informationCerebrospinal Fluid Glucose and Protein in Disposition and Treatment Decisions
298 BRIEF REPORTS Givens et al. CSF GLUCOSE AND PROTEIN Cerebrospinal Fluid Glucose and Protein in Disposition and Treatment Decisions Routine laboratory analysis performed when bacterial meningitis is
More informationEDUCATIONAL COMMENTARY THROAT CULTURES LEARNING OUTCOMES. Upon completion of this exercise, the participant should be able to:
EDUCATIONAL COMMENTARY THROAT CULTURES LEARNING OUTCOMES Upon completion of this exercise, the participant should be able to: distinguish three types of hemolysis produced by bacterial colonies. discuss
More informationMANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSP There are no translations available. MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
More informationCost-Effectiveness of Blood Cultures for Adult Patients with Cellulitis
1483 Cost-Effectiveness of Blood Cultures for Adult Patients with Cellulitis Bezalel Perl, 1 Nathan P. Gottehrer, 2 David Raveh, 1 Yechiel Schlesinger, 1 Bernard Rudensky, 3 and Amos M. Yinnon 1 From the
More informationMonitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014
Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 3 June 214 1. The cumulative cases report since December 21 and cases report during April to June 214 During 1 April to 3 June
More informationBACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )
BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year 2012-2013) 19. 10. 2012. Introduction in microbiology, bacterial taxonomy, general bacterial prop Bacterial structures, biosynthesis
More information